These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29931834)

  • 1. Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.
    Mi Y; Zhao Y; Shi F; Zhang M; Wang C; Liu X
    Asia Pac J Clin Oncol; 2019 Apr; 15(2):e11-e19. PubMed ID: 29931834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
    Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer.
    Eissa S; Zohny SF; Swellam M; Mahmoud MH; El-Zayat TM; Salem AM
    Clin Biochem; 2008 Nov; 41(16-17):1335-41. PubMed ID: 18804101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of combined detection with urinary bladder cancer antigen, hyaluronic acid and cytokeratin 20 in diagnosis of bladder cancer].
    Pu XY; Wang ZP; Chen YR; Wu YL; Wang HP; Wang XH
    Ai Zheng; 2008 Sep; 27(9):970-3. PubMed ID: 18799038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin-20 immunocytochemistry in voided urine cytology and its comparison with nuclear matrix protein-22 and urine cytology in the detection of urothelial carcinoma.
    Srivastava R; Arora VK; Aggarwal S; Bhatia A; Singh N; Agrawal V
    Diagn Cytopathol; 2012 Sep; 40(9):755-9. PubMed ID: 22888081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
    Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection.
    Salomo K; Huebner D; Boehme MU; Herr A; Brabetz W; Heberling U; Hakenberg OW; Jahn D; Grimm MO; Steinbach D; Horstmann M; Froehner M; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1757-1769. PubMed ID: 28484844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity, cytokeratin 20 and cytokeratin 19 in urine cells of bladder cancer patients.
    Morsi MI; Youssef AI; Hassouna ME; El-Sedafi AS; Ghazal AA; Zaher ER
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):82-92. PubMed ID: 17237854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of urine-based markers for diagnosis of bladder cancer.
    Eissa S; Swellam M; Amin A; Balbaa ME; Yacout GA; El-Zayat TM
    Med Oncol; 2011 Jun; 28(2):513-8. PubMed ID: 21437743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
    Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
    Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
    World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
    Rotem D; Cassel A; Lindenfeld N; Mecz Y; Sova Y; Resnick M; Stein A
    Eur Urol; 2000 May; 37(5):601-4. PubMed ID: 10765100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
    Pichler R; Fritz J; Tulchiner G; Klinglmair G; Soleiman A; Horninger W; Klocker H; Heidegger I
    BJU Int; 2018 Jan; 121(1):29-37. PubMed ID: 28941000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of bladder tumor fibronectin in patients with bladder tumor: a systematic review with meta-analysis.
    Yang X; Huang H; Zeng Z; Zhao L; Hu P; He D; Tang X; Zeng Z
    Clin Biochem; 2013 Oct; 46(15):1377-82. PubMed ID: 23735602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: a meta-analysis.
    Ding M; Li Y; Wang H; Lv Y; Liang J; Wang J; Li C
    Int J Clin Exp Med; 2015; 8(9):15432-40. PubMed ID: 26629032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer.
    Wang Z; Wang X; Zhang D; Yu Y; Cai L; Zhang C
    Tumour Biol; 2017 Jun; 39(6):1010428317709990. PubMed ID: 28639914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study.
    Li HX; Li M; Li CL; Ma JH; Wang MR; Rao J; Pan QJ
    Anal Quant Cytol Histol; 2010 Feb; 32(1):45-52. PubMed ID: 20701087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance of Confocal Laser Endomicroscopy for the Detection of Bladder Cancer: Systematic Review and Meta-Analysis.
    Wu J; Wang YC; Luo WJ; Dai B; Ye DW; Zhu YP
    Urol Int; 2020; 104(7-8):523-532. PubMed ID: 32554957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
    Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
    Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.